key: cord-0790481-n2sf12aa
authors: Ahmad, Dr Zohra; Goswami, Dr Sneha; Paneerselvam, Dr Ambikapathi; Kabilan, Dr Kaviraj; Chowdhury, Dr Himanshu; Roy, Dr Ambuj; Guleria, Dr Randeep; Soni, Dr Kapil Dev; Baruah, Dr Udismita; Das, Dr Chandan J
title: Imaging of Coronavirus Disease 2019 infection from Head to toe: A primer for the radiologist
date: 2021-07-05
journal: Curr Probl Diagn Radiol
DOI: 10.1067/j.cpradiol.2021.06.015
sha: 7d708dbe13eddd7fa798dbd71e1c8dd92bad6fdf
doc_id: 790481
cord_uid: n2sf12aa

Coronavirus Disease 2019 (COVID-19) disease has rapidly spread around the world after initial identification in Wuhan, China, in December 2019. Most common presentation is mild or asymptomatic disease, followed by pneumonia, and rarely- multiorgan failure and Acute Respiratory Distress Syndrome (ARDS). Knowledge about the pathophysiology, imaging and treatment of this novel virus is rapidly evolving due to ongoing worldwide research. Most common imaging modalities utilized during this pandemic are chest radiography and HRCT with findings of bilateral peripheral, mid and lower zone GGO/ consolidation, vascular enlargement and crazy paving. HRCT is also useful for prognostication and follow-up of severely ill COVID-19 patients. Portable radiography allows follow-up of ICU patients & obviates the need of shifting critically ill patients and disinfection of CT room. As the pandemic has progressed, numerous neurological manifestations have been described in COVID-19 including stroke, white matter hyperintensities and demyelination on MRI. Varying abdominal presentations have been described, which on imaging either show evidence of COVID-19 pneumonia in lung bases or show abdominal findings including bowel thickening and vascular thrombosis. Numerous thrombo-embolic and cardiovascular complications have also been described in COVID-19 including arterial and venous thrombosis, pulmonary embolism and myocarditis. It is imperative for radiologists to be aware of all the varied faces of this disease on imaging, as they may well be the first physician to suspect the disease. This article aims to review the multimodality imaging manifestations of COVID-19 disease in various organ systems from head to toe.

spread worldwide leading to a substantial public health crisis. The worst affected countries are the USA, Brazil, and India, the total number of cases in the world being over 167 million as of May 24, 2021 1 .

Common COVID-19 symptoms are fever, cough, dyspnea, myalgia, fatigue, and anosmia. As the pandemic has progressed, abdominal symptoms like loss of appetite, nausea, vomiting, diarrhea, and abdominal pain have also been noted 1 . An early study reported that approximately 81% of patients of COVID-19 had mild symptoms, 14% had severe disease, including pneumonia and dyspnoea, and 5% had critical illness including multiorgan failure and respiratory failure 2 . It has been reported that COVID-19 disease predisposes to a prothrombotic state marked by elevated D-dimer and thrombocytopenia, potentially resulting in thromboembolic complications. In addition, an immune-mediated cytokine storm in the second week of this viral illness may set into motion severe complications like ARDS and multiorgan disease, which may be fatal. The gold standard for the diagnosis of COVID-19 is real time polymerase chain reaction (RT-PCR) on nasopharyngeal/oropharyngeal swab; however, its sensitivity is reported to be only 30-60 % due to limitations of sample collection, transportation, and kit performance 3 .

Radiography is insensitive in identifying early disease but has a valuable role in the follow-up and prognostication of diagnosed patients. Typical chest CT findings of COVID-19 pneumonia are peripheral, multifocal GGO, and consolidative opacities. 

The inhaled virus SARS-CoV-2 binds to the epithelial cells of the nasal cavity and starts multiplying, following which it enters alveolar epithelial cells in the lung by binding to angiotensinconverting enzyme 2 (ACE-2) receptors. Cell entry is via binding of the spike protein of SARS-CoV-2 virus to the ACE-2 receptor. 5 ACE-2 receptor is expressed in various sites apart from the lung epithelium, including cardiovascular endothelium, small bowel, liver, biliary epithelial cells, pancreatic islet cells, kidney, and brain, making these organs prone to injury. It has been postulated that receptor expression may potentiate cytotoxic effects by aiding local viral infection and replication.

Due to the destruction of cells expressing ACE-2, there is relative ACE-2 deficiency leading to derangement of Renin-Angiotensin system, elevated Angiotensin-II, and reduced Angiotensin1-7, which potentiates endothelial inflammation, thrombosis, and hypertension 7 . This may also play a role in multiorgan injury to the heart, kidney, and liver.

COVID-19 is recognized as a multisystem disease due to its affinity for ACE-2 receptor and cytokine-mediated inflammation. Early investigations suggest that the most common laboratory findings are elevated D-dimer levels, mild thrombocytopenia, and PT prolongation, which are associated with increased mortality 7, 8 . Decreased lymphocyte count due to direct cytotoxic action, leukocytosis, and neutrophilia due to hyperinflammatory response is also seen in COVID-19 patients 8 . Patients with COVID-19 show an increased risk of vascular thrombosis, manifesting as deep vein thrombosis, pulmonary embolism, arterial stroke, and visceral or peripheral artery thrombosis. Above hemostatic abnormalities are primarily related to an inflammatory syndrome characterized by elevated cytokines, including IL-1 and IL-6, referred to as thromboinflammation 9 . The various system involvement is described below with its imaging features.

The most common neurological symptoms reported in COVID-19 are headache, altered consciousness, pathological wakefulness after sedation, agitation, and confusion. Jain et al. 8 

Mahammedi et al. 10 reported that the most common positive neuroimaging studies revealed stroke and the former described that finding of either large ischemic or hemorrhagic stroke was associated with high mortality[ Figure 1&3 ].. Chougar et al. 11 found several cerebrovascular complications such as ischemic stroke, microhemorrhages, deep vein thrombosis, cytotoxic lesions of corpus callosum, multifocal white matter enhancing lesions, and basal ganglia abnormalities in COVID-19 patients.

Kandemirli et al. 12 found increased cortical signal on FLAIR (Fluid-attenuated inversion recovery), cortical diffusion restriction, cortical blooming, leptomeningeal enhancement, and subcortical and deep white matter abnormality. Radmanesh et al. 13 described two patterns of MRI findings, one being deep and subcortical white matter hyperintensity with mild diffusion restriction and the other one being diffuse subcortical and callosal microhemorrhages[ Figure 2 ] .Kremer et al. 14 described mainly three patterns of MRI findings after excluding ischemic infarcts-medial temporal lobe hyperintensity, non-confluent white matter hyperintensities with diffusion restriction with or without enhancement with or without microhemorrhages and isolated widespread microhemorrhages.

The various proposed mechanisms for neurological implications include the following -Direct central nervous system spread, and neurotropism is supported by evidence of earlier SARS-CoV strains gaining access to the CNS via olfactory pathways or the bloodstream and known to cause meningitis and encephalitis 15 . Another proposed etiology is indirect neurologic involvement due to an excessive systemic proinflammatory response, which may cause widespread dysregulation of homeostasis with coagulopathy and increase the risk of acute cerebrovascular diseases.

COVID-19 may also lead to parainfectious autoimmune-based neurologic complications such as acute disseminated encephalomyelitis (ADEM) and Guillain Barré syndromes, which are recognized complications of microbial infections 16, 17 . Lastly, since most patients were admitted to ICUs forARDS, more general assumptions may also be considered, such as delayed post-hypoxic leukoencephalopathy, metabolic or toxic encephalopathy, and posterior reversible encephalopathy syndrome (PRES) 18, 19 .

Various patterns of neurological abnormalities in COVID-19 patients are summarized in Table 1 .

Common clinical symptoms of COVID19 pneumonia include fever, cough, and expectoration, while few present with vomiting, dyspnoea, and low oxygen saturation levels 20 . Fleishner society recommends imaging in symptomatic COVID-19 patients with worsening respiratory status or those with moderate/severe disease. Imaging is not recommended in asymptomatic/mild patients or for primary diagnosis or screening of patients 21 . Chest radiographs were found to be insensitive in diagnosing COVID-19 pneumonia; however, findings of multifocal haziness and consolidations have been described 22 . With the progression of pneumonia, consolidations may become more confluent with an ARDS type diffuse involvement in later stages [ Figure 4 ].

Point of care ultrasound is a useful diagnostic and prognostic tool for COVID-19, particularly in ICU and isolation wards 23 . Lung ultrasound findings in COVID-19 include thickened pleural lines(shred sign), vertically oriented echogenic B lines, multifocal consolidations with air bronchograms, and A-lines during the recovery phase 24, 25 .

Literature of COVID-19 pneumonia has been focused on chest CT due to its high sensitivity to diagnose lung abnormalities. Tao et al . 3 described a high sensitivity of CT to diagnose COVID-19 with RT-PCR as the gold standard. They also found positive CT findings in 75 % of patients in a group of 413 suspected COVID patients with a negative RT-PCR. Similar findings were reported by Korkmaz et al . 26 .

This underscores the need to utilise CT as a problem-solving tool in the present scenario. CT findings of COVID-19 have been described as multifocal bilateral GGO/mixed GGO-consolidation with rounded morphology and bilateral, multifocal, peripheral, and lower lobe distribution 27,28 [ Figure 5 ]. Other common features of interlobular septal thickening, air bronchogram, and vascular enlargement and less common findings of reverse halo, nodule with halo, subpleural line sign, subpleural transparent line sign, fibrotic streaks, bronchiectasis, and bronchus deformation were also described. [ Figure 6 a-b]. A variant of reverse halo signbull's eye sign has been described in COVID-19, which consists of a central ground-glass nodule surrounded by an inner ring of air and an outer ring of ground glass. These likely represent areas of organizing pneumonia 29 . Pleural effusion, pericardial effusion, lymphadenopathy, cavitation, and pneumothorax are uncommon findings that may be seen on disease progression 30, 31 .

Temporal follow-up of CT findings has revealed initial unifocal GGO followed by an increase in number and size of GGO, progressing to mixed GGO-consolidation with or without crazy paving pattern reaching a peak around ten days, thereafter showing slow resolution with linear subpleural consolidative opacities or reverse halo sign which is typical to organizing pneumonia 30,32 [ Figure 7 ]. Pulmonary fibrosis may develop with time, which manifests as mild to severe subpleural and peribronchovascular fibrosis, macrocystic lung changes, and bronchiectasis. CT helps evaluate post-COVID fibrosis, especially in those patients who present with persistent cough and dyspnea 33, 34 [ Figure 6 c-f].

Vascular and perfusion abnormalities, including dilatation, tortuosity of pulmonary vessels not limited to the area of GGO, mosaic perfusion, focal oligemia, and focal hyperemia have been identified in CT images of COVID-19 patients. The typical response to pneumonia is hypoxic vasoconstriction in the consolidated lung. In COVID-19, there is inflammation-mediated paradoxical vascular dilatation in the consolidated lung. This leads to shunting of blood to poorly ventilated areas of lung parenchyma, which further exacerbates hypoxia due to ventilation-perfusion mismatch 35 .

The various pulmonary findings of COVID-19 are summarized in Table 2 .

Various reports of coagulopathy and acute pulmonary embolism (PE) have been published in recent times, indicating a higher risk of thromboembolic events in COVID-19 pneumonia. An elevated risk of developing PE was associated with these factors-obesity, elevated D-dimer, elevated CRP, and rising D-dimer values over time 36 [ Figure 8 ].

In a study comprising 100 COVID-19 patients, a 23% prevalence of acute pulmonary thromboembolism was found 37 . Another study showed that patients with COVID-19 infection undergoing lower extremity CT angiography (CTA) had a higher propensity for lower extremity clots when compared to the controls 38 . A study on 81 critically ill patients found the incidence of venous thromboembolism (VTE) to be 25% 39 .

COVID-19 predisposes to arterial and venous thrombosis, the imaging features of which are not specific and appear similar to those associated with other diseases[ Figure 9 ]. However, if radiologists are familiar with its prevalence and pathogenesis in these patients, it can aid in early detection and a more favorable outcome. Since these patients undergo aggressive anticoagulation therapy, there is a possibility of increased incidence of bleeding complications which can be diagnosed on imaging.

COVID-19 can affect the cardiovascular system through direct and indirect mechanisms, such as myocardial injury, acute coronary syndromes (ACS), right ventricular dysfunction/ acute cor pulmonale, arrhythmias, and cardiogenic shock 40 . There have been reports of clinically diagnosed myocarditis with supplemental imaging findings 41,42 [ Figure 9 ,10]. Abnormalities of the cardiac rhythm including newonset atrial fibrillation, sinus node dysfunction, complete heart block, and ventricular arrhythmias have also been described 20 .

Puntmann et al. 43 found contrast-enhanced MRI (CEMRI) evidence of cardiovascular involvement and myocardial inflammation in 78 % and 60% respectively of recently recovered COVID-19 patients without any relation to severity and course of acute illness or preexisting conditions. The CEMRI abnormalities detected were elevated native T1, elevated native T2, delayed myocardial enhancement, and pericardial enhancement 43 .

A multitude of factors has been recognized in the pathophysiology of cardiovascular manifestation. ACE-2 receptor is widely present in the cardiovascular tissuein cardiac myocytes, fibroblasts, and endothelial cells, suggesting a role in a direct viral injury mechanism 44, 45 . It has been proposed that patients who have preexisting cardiovascular disease have increased ACE-2 levels, predisposing them to complications 46, 47 . Myocarditis has been suggested as an acute cause of cardiac dysfunction, and it has been postulated that the viral load correlates with the severity of myocardial injury. Another mechanism is cytokine storm or systemic inflammatory response syndrome, which can cause myocardial injury due to demand ischemia 48 . Troponin levels are often raised primarily in severe cases and are associated with poor prognosis. Increased pulmonary vascular pressure occurring secondary to ARDS and pulmonary thromboembolism can cause right ventricular dysfunction 49 . While various viral infections are a risk factor for myocardial infarction(MI) 50 , the risk is higher with COVID-19, which could be related to the increased coagulability causing an increase in thrombotically mediated MI.

The various cardiovascular complications of COVID-19 are summarized in Table 3 .

Multisystem inflammatory syndrome in children (MIS-C was first described as a Kawasaki-like syndrome in patients with a history of prior contact with a COVID-19 patient. It has been proposed that MIS-C is the result of a post infectious phenomenon due to abnormal IgG antibody mediated enhancement of the disease. An alternative hypothesis suggests that coronaviruses due to their known ability to block interferon responses can result in a delayed cytokine storm leading to MIS-C 51 .

Case series and studies have described a broad spectrum of multisystem imaging findings in this syndrome, including perihilar bronchial wall thickening, perihilar or lower lobe consolidations, rapid development of pulmonary edema, ARDS, pulmonary embolism, cardiomegaly, coronary aneurysms, pericardial effusion, gall bladder wall thickening, splenic infarcts, echogenic kidneys, right iliac fossa bowel thickening, and mesenteric lymphadenopathy 52, 53 . MIS-C related myocarditis imaging findings have been described on echocardiography to show transient systolic dysfunction and on cardiac MRI to show myocardial edema without enhancement 54 .

Tian et al 20 

There is significant co-expression of ACE-2 and Transmembrane protease, serine (TMPRSS) in cells of proximal convoluted tubules, which places them at high risk of injury due to SARS-CoV-2 67 .

Cytokine storm may also have a role in renal injury. A review by Zaim et al. described that 0.5-19 % of COVID-19 patients may show varying degrees of renal injury. Possible renal manifestations of COVID-19 include acute kidney injury, electrolyte abnormalities, proteinuria, and hematuria 68 . Imaging-wise, this may be seen on ultrasound as increased renal cortical echogenicity and altered corticomedullary differentiation. This knowledge is relevant for radiologists as they must exercise caution while advising contrast-enhanced CT, which may be replaced by ultrasonography or non-contrast MRI.

Myalgia, arthralgia and fatigue have been commonly reported symptoms in COVID-19 69 

The novel Coronavirus brought the whole world to a standstill in 2020. Being a new disease, its clinical manifestations, radiological imaging, and treatment have rapidly evolved owing to ongoing research. It has been realized that the effects of COVID-19 are not limited to the lung and involve several organ systems in the body. The role of imaging is ancillary to the RTPCR test for diagnosis but indispensable for prognosticating and following up COVID-19 pneumonia. Imaging is also imperative in diagnosing thromboembolism, complications in brain, cardiovascular system, gastrointestinal and hepatobiliary system. Acute necrotizing hemorrhagic encephalopathy 80 The case report revealed bilateral thalamic, medial temporal, and subinsular regions with hemorrhagic change & rim enhancement.

Breach in the blood-brain barrier due to cytokine storm rather than demyelination. 81  Affects lung in previously involved sites.

 Severe cases, diffuse lung involvement with potential candidate for lung transplant.

Residual fibrosis after resorption of pneumonitis Small pseudocyst was also noted in lesser sac (arrow). He later tested positive for COVID-19

Live): 26,184,512 Cases and 867,374 Deaths from COVID-19 Virus Pandemic -Worldometer

The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) -China

Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases

Chest CT of COVID-19 in patients with a negative first RT-PCR test: Comparison with patients with a positive first RT-PCR test. Medicine (Baltimore)

CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan

COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies

COVID-19 -A Complex Multi-system and Coagulation Disease

COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome

Thromboembolic events and Covid-19

Imaging in Neurological Disease of Hospitalized

Patients: An Italian Multicenter Retrospective Observational Study

Retrospective Observational Study of Brain Magnetic Resonance Imaging Findings in Patients with Acute SARS-CoV-2 Infection and Neurological Manifestations

Brain MRI Findings in Patients in the Intensive Care Unit with COVID-19 Infection

COVID-19 -associated Diffuse Leukoencephalopathy and Microhemorrhages

Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study

Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms

Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence

Guillain-Barré Syndrome Associated with SARS-CoV-2

Delayed Post-hypoxic Leukoencephalopathy: A Case Series and Review of the

Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19

Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission

The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society

Back to the basics: Study of portable chest radiographic findings in 116 COVID-19 positive patients in an Indian tertiary care hospital

Can Lung US Help Critical Care Clinicians in the Early Diagnosis of Novel Coronavirus (COVID-19) Pneumonia? Radiology

Chinese Critical Care Ultrasound Study Group (CCUSG). Findings of lung ultrasonography of novel corona virus pneumonia during the 2019-2020 epidemic

Lung Ultrasound Findings in Patients With Coronavirus Disease (COVID-19)

Chest CT in COVID-19 pneumonia: correlations of imaging findings in clinically suspected but repeatedly RT-PCR test-negative patients

Clinical Features and Chest CT Manifestations of Coronavirus Disease 2019 (COVID-19) in a Single-Center Study in Shanghai, China

Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study

The bullseye sign: A variant of the reverse halo sign in COVID-19 pneumonia

Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients

CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China

COVID-19 pneumonia: A review of typical CT findings and differential diagnosis

Pulmonary fibrosis secondary to COVID-19: a call to arms?

COVID-19 interstitial pneumonia: monitoring the clinical course in survivors

Pulmonary Vascular Manifestations of COVID-19 Pneumonia. Radiol Cardiothorac Imaging

Acute Pulmonary Embolism and COVID-19

Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected with Pulmonary CT Angiography

Lower extremity arterial thrombosis associated with COVID-19 is characterized by greater thrombus burden and increased rate of amputation and death

Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia

COVID-19 and the Heart

Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin

Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)

Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Regulation of ACE2 in cardiac myocytes and fibroblasts

Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system

Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling

SARS-CoV-2 and viral sepsis: observations and hypotheses. The Lancet

Right heart function during acute respiratory distress syndrome

Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection

Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children

Imaging Findings in Multisystem Inflammatory Syndrome in Children (MIS-C)

Spectrum of Imaging Findings on Chest Radiographs, US, CT, and MRI Images in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19

Cardiac MRI of Children with Multisystem Inflammatory Syndrome (MIS-C) Associated with COVID-19: Case Series

Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study

Lung Base Findings of Coronavirus Disease (COVID-19) on Abdominal CT in Patients With Predominant Gastrointestinal Symptoms

CT Scans Obtained for Nonpulmonary Indications: Associated Respiratory Findings of COVID-19

Abdominopelvic CT findings in patients with novel coronavirus disease 2019 (COVID-19)

Abdominal Presentation of COVID-19

Abdominal Imaging Findings in COVID-19: Preliminary Observations

Case Report: COVID-19 Masquerading as an Acute Surgical Abdomen

An Atypical Presentation of COVID-19 in a Previously Healthy Young Male With a Rare Cause of Abdominal Pain

Clinical Features of COVID-19-Related Liver Functional Abnormality

Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study

Covid-19 may present with acute abdominal pain

ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection

Extrapulmonary manifestations of COVID-19: Radiologic and clinical overview

Extrapulmonary manifestations of COVID-19

Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients

Musculoskeletal Consequences of COVID-19

Musculoskeletal involvement of COVID-19: review of imaging

Neuromuscular presentations in patients with COVID-19

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection

Viral arthritis and COVID-19

A case of psoriatic arthritis triggered by SARS-CoV-2 infection. Rheumatology (Oxford)

Cutaneous manifestations in COVID-19: a first perspective

Cutaneous manifestations of COVID-19: A preliminary review

COVID-19-Associated Cytotoxic Lesions of the Corpus Callosum

A first case of meningitis/encephalitis associated with SARS-Coronavirus-2

COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features

Imaging of Acute Disseminated Encephalomyelitis. Neuroimaging Clin